Literature DB >> 2435321

Surface hydrophobicity of hemoglobins A, F and S determined by gel filtration column chromatography in high-phosphate buffer.

K Adachi.   

Abstract

We found that hemoglobins A, F and S could be separated on TSK-GEL-SW columns by differences in surface hydrophobicity when eluted with 1.8 M phosphate buffer, pH 7.4. The elution pattern of the oxy- and deoxy-forms of hemoglobins A, S and F from a TSK-GEL-SW-type gel filtration column is useful for measuring surface hydrophobicity. The elution volumes of oxyhemoglobins F, A and S on the TSK-GEL-SW column in 1.8 M potassium phosphate buffer, pH 7.4, related linearly to the log of their solubility; the higher the surface hydrophobicity, the lower the solubility. There was no linear relationship between the solubilities and the elution volumes of these hemoglobins in the deoxy-form; deoxy-Hb S was far from the lines formed by deoxy-Hb A and deoxy-Hb F. These data suggest that the solubility of oxyhemoglobins is related to simple hydrophobic interactions caused by the total surface hydrophobicity, but the extremely low solubility of deoxy-Hb S must be the result of a stereospecific strong hydrophobic interaction between amino acids at the contact regions of deoxy-Hb S molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435321     DOI: 10.1016/0167-4838(87)90257-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Familial secondary erythrocytosis due to increased oxygen affinity is caused by destabilization of the T state of hemoglobin Brigham (α₂β₂(Pro100Leu)).

Authors:  Todd L Mollan; Bindu Abraham; Michael Brad Strader; Yiping Jia; Jay N Lozier; John S Olson; Abdu I Alayash
Journal:  Protein Sci       Date:  2012-08-21       Impact factor: 6.725

2.  Partitioning of benzene in blood: influence of hemoglobin type in humans and animals.

Authors:  Mildred J Wiester; Darrell W Winsett; Judy H Richards; Donald L Doerfler; Daniel L Costa
Journal:  Environ Health Perspect       Date:  2002-03       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.